Skip to main content

KLX 170 (Fenofibrate 54 mg)

Pill with imprint KLX 170 is Yellow, Round and has been identified as Fenofibrate 54 mg. It is supplied by Karalex Pharma.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 54 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KLX 170

Fenofibrate 54 mg KLX 170
Fenofibrate 54 mg KLX 170
Fenofibrate 54 mg KLX 170


KLX 170
54 mg
9.00 mm
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Karalex Pharma
National Drug Code (NDC)
Inactive Ingredients
betadex, silicon dioxide, calcium phosphate dihydrate dibasic, docusate sodium, sodium benzoate, hypromelloses, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide, D&C Yellow No. 10, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.